Purchase Order 75N92019P00346
- Not listed
- This contract award to Pacific Biosciences of California, Inc. is for the delivery of a PacBio RS II DNA Sequencer System to the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The $627,500 firm-fixed-price contract has a completion date of July 31, 2014. As the original equipment manufacturer, Pacific Biosciences has established itself as a key supplier of specialized sequencing solutions to federal agencies. The company has been...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $63,802 purchase order to Pacific Biosciences of California, Inc. for SMRT cell and sequence reagents to operate the Sequel II sequencing platform. As a prime contractor, Pacific Biosciences will deliver the requested products to support genomic sequencing efforts at their West Menlo Park, California location of performance. The firm-fixed price contract runs from August...
- This is a firm-fixed price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to Pacific Biosciences of California, Inc. for a PacBio Sequencing System. The $84,000.00 contract was awarded on April 16, 2015 with a completion date of June 26, 2016. Pacific Biosciences is a small business manufacturer that specializes in providing advanced DNA/RNA sequencing systems, reagents, and related services to federal agencies. The company has established...
- This federal contract award is for the supply and installation of a Sequel II DNA sequencing machine by Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment. The contract, valued at $522,500.00, was awarded on May 13, 2019 by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations. The contract is a firm-fixed price purchase order with a completion date of June 9, 2019. Pacific...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID) to Pacific Biosciences of California, Inc., a for-profit manufacturer of genomic sequencing equipment and consumables. The $363,000.00 firm-fixed-price purchase order is for the provision of a Sequel Instrument, which is part of Pacific Biosciences' proprietary single molecule, real-time (SMRT) sequencing technology. This award was not set aside for any specific business type. Pacific...
- This federal contract award to Pacific Biosciences of California, Inc. is for the procurement of PacBio Revio Sequencer Systems by the National Human Genome Research Institute (NHGRI), a component of the U.S. Department of Health and Human Services. The contract has a ceiling value of $540,088.00 and is a firm fixed-price purchase order with an ultimate completion date of August 12, 2024. The award was made on June 26, 2024, and there was no set-aside designation used. Pacific Biosciences is a...
- This firm-fixed-price purchase order for $32,500.00 was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Pacific Biosciences of California, Inc. to provide their Sequel and Sequel II DNA/RNA sequencing systems, reagent kits, consumables, and preventative maintenance services. This contract is not designated as a set-aside. Pacific Biosciences is a manufacturer of specialized scientific equipment and a major provider of sequencing...
- This federal contract award was made by the National Human Genome Research Institute, a civilian agency, to Pacific Biosciences of California, Inc., a for-profit manufacturer of scientific equipment. The $84,000 firm-fixed price purchase order is for the delivery of Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing platforms, associated consumables, and support services. Pacific Biosciences has established itself as a key supplier of specialized long-read sequencing solutions to...
- This $274,176 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Pacific Biosciences of California, Inc., a for-profit manufacturer. The contract is for the delivery of PacBio Revio sequencing reagents, which support the agency's genomic research initiatives. Pacific Biosciences is the original equipment manufacturer for the proprietary PacBio Sequel and Sequel II DNA/RNA sequencing...
- This federal contract award to Pacific Biosciences of California, Inc., a for-profit manufacturer, is for the purchase of reagents for the company's proprietary RSII and Sequel DNA sequencing systems. The $76,662 firm-fixed price contract was awarded by the National Institute of Standards and Technology (NIST), a civilian federal agency, on August 31, 2016, with a completion date of August 30, 2017. Pacific Biosciences holds two relevant Indefinite Delivery Indefinite Quantity (IDIQ) contract...
This federal contract award to Pacific Biosciences of California, Inc. has a ceiling value of $93,401.00 and was issued by the National Heart Lung and Blood Institute, a civilian agency within the National Institutes of Health (NIH). The purpose of this Firm Fixed Price purchase order is to procure Pacific Biosciences reagents for use by the NIH Intramural Sequencing Center. This award was not set aside for any specific business category. Pacific Biosciences is the prime contractor, and they have been awarded previous federal prime contracts and grants as the original equipment manufacturer of their proprietary single molecule, real-time (SMRT) sequencing technology. The company has established itself as a key supplier of specialized sequencing solutions to various federal civilian agencies to support their genomic research initiatives across fields such as agriculture, infectious diseases, and biotechnology.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $93.4k | 8/21/19 |